Crossmark

Effectiveness and safety of tocilizumab in monotherapy in biologic-naïve and non-naïve patients with rheumatoid arthritis in a real-world setting

Crossref DOI link: https://doi.org/10.1016/j.reuma.2021.12.001

Published Print: 2022-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Marsal Barril, Sara

Martin-Martinez, Mª Auxiliadora

Blanco-Garcia, Francisco Javier

Fernández-Nebro, Antonio

García de Vicuña, Rosario

Tornero-Molina, Jesús

Sánchez-Alonso, Fernando

Novella-Navarro, Marta

Escudero-Contreras, Alejandro

Alegre-Sancho, Juan José

Urruticoechea-Arana, Ana

Bustabad-Reyes, Maria Sagrario

Trenor-Larraz, Pilar

Pérez-Sandoval, Trinidad

Tevar-Sánchez, Maria Isabel

Sánchez-Costa, Jesús T.

Raya-Álvarez, Enrique
License Information

Text and Data Mining valid from 2022-12-01

stm-asf valid from 2022-12-01

stm-asf valid from 2022-12-01

stm-asf valid from 2022-12-01

stm-asf valid from 2022-12-01

stm-asf valid from 2022-12-01
More Information

This article is maintained by: Elsevier

Article Title: Effectiveness and safety of tocilizumab in monotherapy in biologic-naïve and non-naïve patients with rheumatoid arthritis in a real-world setting

Journal Title: Reumatología Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reuma.2021.12.001

Content Type: article

Copyright: © 2021 Published by Elsevier España, S.L.U.